KabaFusion (the “Company”), a nationally recognized leader in home and alternative site infusion, and Nautic Partners (“Nautic”) announce that Nautic has signed a definitive agreement to make a significant investment in KabaFusion. KabaFusion’s clinician-led management team will remain significant investors and continue to lead the Company, while Novo Holdings will exit its successful investment in the Company. Headquartered in Cerritos, CA and Lexington, MA, KabaFusion was founded in 2010 by Chief Executive Officer Dr. Sohail Masood, a pioneer in patient-focused intravenous immunoglobulin (IVIG) infusion therapies with more than three decades of clinical experience. Today, KabaFusion is licensed to serve patients in 45 states through its expansive network of 32 infusion pharmacies and 19 ambulatory infusion suites.
Read the full article: KabaFusion and Nautic Partners Announce Signing of Significant Growth Investment //
Source: https://www.businesswire.com/news/home/20250826047615/en/KabaFusion-and-Nautic-Partners-Announce-Signing-of-Significant-Growth-Investment